Search

Masoud H. Noori

Examiner (ID: 3784, Phone: (571)272-2185 , Office: P/2855 )

Most Active Art Unit
2855
Art Unit(s)
2855, 2214, 2856, 2616
Total Applications
3955
Issued Applications
3448
Pending Applications
170
Abandoned Applications
350

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17356672 [patent_doc_number] => 20220017468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR IMBALANCE [patent_app_type] => utility [patent_app_number] => 17/332805 [patent_app_country] => US [patent_app_date] => 2021-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38741 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17332805 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/332805
Isoquinoline compounds and their use in treating AhR imbalance May 26, 2021 Issued
Array ( [id] => 18405763 [patent_doc_number] => 20230167114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => MACROCYCLIC JAK INHIBITOR AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/999743 [patent_app_country] => US [patent_app_date] => 2021-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9240 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999743 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/999743
MACROCYCLIC JAK INHIBITOR AND USE THEREOF May 20, 2021 Pending
Array ( [id] => 19097648 [patent_doc_number] => 20240116876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => SOCE Inhibitors and Therapeutic Uses Thereof [patent_app_type] => utility [patent_app_number] => 17/925738 [patent_app_country] => US [patent_app_date] => 2021-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28771 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925738 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/925738
SOCE Inhibitors and Therapeutic Uses Thereof May 18, 2021 Pending
Array ( [id] => 18492224 [patent_doc_number] => 11697634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-11 [patent_title] => Method and mixture to form functionalized cyclic compounds [patent_app_type] => utility [patent_app_number] => 17/322798 [patent_app_country] => US [patent_app_date] => 2021-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14750 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 230 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17322798 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/322798
Method and mixture to form functionalized cyclic compounds May 16, 2021 Issued
Array ( [id] => 18434269 [patent_doc_number] => 20230181563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => AKT3 MODULATORS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/923696 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23296 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923696 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/923696
AKT3 MODULATORS AND METHODS OF USE THEREOF May 6, 2021 Pending
Array ( [id] => 18418443 [patent_doc_number] => 20230172901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS [patent_app_type] => utility [patent_app_number] => 17/923782 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19371 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923782 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/923782
COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS May 6, 2021 Pending
Array ( [id] => 18932290 [patent_doc_number] => 11884697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-30 [patent_title] => Oxysterols and methods of use thereof [patent_app_type] => utility [patent_app_number] => 17/242860 [patent_app_country] => US [patent_app_date] => 2021-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27274 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242860 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/242860
Oxysterols and methods of use thereof Apr 27, 2021 Issued
Array ( [id] => 18748337 [patent_doc_number] => 11807633 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-07 [patent_title] => Chromene derivatives as inhibitors of TCR-Nck interaction [patent_app_type] => utility [patent_app_number] => 17/240041 [patent_app_country] => US [patent_app_date] => 2021-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28307 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 279 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240041 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/240041
Chromene derivatives as inhibitors of TCR-Nck interaction Apr 25, 2021 Issued
Array ( [id] => 17022272 [patent_doc_number] => 20210246143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => PYRROLOPYRROLE COMPOSITIONS AS PYRUVATE KINASE (PKR) ACTIVATORS [patent_app_type] => utility [patent_app_number] => 17/239364 [patent_app_country] => US [patent_app_date] => 2021-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25148 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17239364 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/239364
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators Apr 22, 2021 Issued
Array ( [id] => 18794111 [patent_doc_number] => 11827867 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-28 [patent_title] => Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents [patent_app_type] => utility [patent_app_number] => 17/301792 [patent_app_country] => US [patent_app_date] => 2021-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 28200 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17301792 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/301792
Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents Apr 13, 2021 Issued
Array ( [id] => 18503541 [patent_doc_number] => 11701331 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-18 [patent_title] => Toxic aldehyde related diseases and treatment [patent_app_type] => utility [patent_app_number] => 17/227568 [patent_app_country] => US [patent_app_date] => 2021-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 25592 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227568 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/227568
Toxic aldehyde related diseases and treatment Apr 11, 2021 Issued
Array ( [id] => 17618908 [patent_doc_number] => 11337934 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-05-24 [patent_title] => Compositions including a cannabinoid and protocatechuic acid [patent_app_type] => utility [patent_app_number] => 17/225584 [patent_app_country] => US [patent_app_date] => 2021-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7536 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17225584 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/225584
Compositions including a cannabinoid and protocatechuic acid Apr 7, 2021 Issued
Array ( [id] => 18581515 [patent_doc_number] => 20230263767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => COMPOSITION FOR PREVENTING, ALLEVIATING, OR TREATING INFLAMMATORY DISEASE CONTAINING ISOOKANIN OR SALT THEREOF AS ACTIVE INGREDIENT [patent_app_type] => utility [patent_app_number] => 18/020120 [patent_app_country] => US [patent_app_date] => 2021-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9589 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18020120 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/020120
COMPOSITION FOR PREVENTING, ALLEVIATING, OR TREATING INFLAMMATORY DISEASE CONTAINING ISOOKANIN OR SALT THEREOF AS ACTIVE INGREDIENT Apr 4, 2021 Issued
Array ( [id] => 19216186 [patent_doc_number] => 20240180890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-06 [patent_title] => VACCINE ADJUVANT [patent_app_type] => utility [patent_app_number] => 18/283158 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13040 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18283158 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/283158
VACCINE ADJUVANT Mar 30, 2021 Pending
Array ( [id] => 17342096 [patent_doc_number] => 20220008427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => 3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS [patent_app_type] => utility [patent_app_number] => 17/216106 [patent_app_country] => US [patent_app_date] => 2021-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19931 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17216106 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/216106
3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus Mar 28, 2021 Issued
Array ( [id] => 17513650 [patent_doc_number] => 11292779 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-04-05 [patent_title] => Process for production of essentially pure D8-tetrahydrocannabinol from cannabidiol extracted from hemp [patent_app_type] => utility [patent_app_number] => 17/214229 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11431 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17214229 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/214229
Process for production of essentially pure D8-tetrahydrocannabinol from cannabidiol extracted from hemp Mar 25, 2021 Issued
Array ( [id] => 17081963 [patent_doc_number] => 20210276969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => CONTINUOUS METHOD FOR PREPARING CARBONATE ESTERS [patent_app_type] => utility [patent_app_number] => 17/209742 [patent_app_country] => US [patent_app_date] => 2021-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8470 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 226 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17209742 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/209742
Continuous method for preparing carbonate esters Mar 22, 2021 Issued
Array ( [id] => 18363813 [patent_doc_number] => 20230145404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => H2O2 WITHOUT DIBC FOR PO PRODUCTION [patent_app_type] => utility [patent_app_number] => 17/911673 [patent_app_country] => US [patent_app_date] => 2021-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13588 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17911673 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/911673
H2O2 WITHOUT DIBC FOR PO PRODUCTION Mar 21, 2021 Pending
Array ( [id] => 18384459 [patent_doc_number] => 11655227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-23 [patent_title] => Production of purified dialkyl-furan-2,5-dicarboxylate (DAFD) in a retrofitted DMT plant [patent_app_type] => utility [patent_app_number] => 17/301003 [patent_app_country] => US [patent_app_date] => 2021-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16994 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17301003 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/301003
Production of purified dialkyl-furan-2,5-dicarboxylate (DAFD) in a retrofitted DMT plant Mar 21, 2021 Issued
Array ( [id] => 19241982 [patent_doc_number] => 12012401 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-18 [patent_title] => Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide [patent_app_type] => utility [patent_app_number] => 17/205558 [patent_app_country] => US [patent_app_date] => 2021-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 58 [patent_no_of_words] => 45799 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 320 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17205558 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/205558
Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide Mar 17, 2021 Issued
Menu